Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EUCRNASDAQ:MCAANASDAQ:RFAINYSE:ROSS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEUCREucrates Biomedical Acquisition$10.04$10.08$9.87▼$10.25$42.27M-0.072,287 shs12,700 shsMCAAMountain & Co. I Acquisition Corp.$11.39$11.39$11.18▼$12.34$160.94M0.0166,611 shsN/ARFAIRF Acquisition Corp II$10.49+0.1%$10.44$10.00▼$10.50$157.48MN/A54,490 shs5,011 shsROSSRoss Acquisition Corp II$11.08$11.08$10.21▼$11.12$151.42M0.02N/AN/AInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEUCREucrates Biomedical Acquisition0.00%0.00%0.00%0.00%0.00%MCAAMountain & Co. I Acquisition Corp.0.00%0.00%0.00%0.00%-1.81%RFAIRF Acquisition Corp II0.00%+0.10%+0.14%+1.60%+1,048,999,900.00%ROSSRoss Acquisition Corp II0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEUCREucrates Biomedical AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AMCAAMountain & Co. I Acquisition Corp.N/AN/AN/AN/AN/AN/AN/AN/ARFAIRF Acquisition Corp IIN/AN/AN/AN/AN/AN/AN/AN/AROSSRoss Acquisition Corp IIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEUCREucrates Biomedical Acquisition 0.00N/AN/AN/AMCAAMountain & Co. I Acquisition Corp. 0.00N/AN/AN/ARFAIRF Acquisition Corp II 0.00N/AN/AN/AROSSRoss Acquisition Corp II 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEUCREucrates Biomedical AcquisitionN/AN/A$0.81 per share12.36($1.25) per shareN/AMCAAMountain & Co. I Acquisition Corp.N/AN/AN/AN/AN/AN/ARFAIRF Acquisition Corp IIN/AN/AN/AN/AN/AN/AROSSRoss Acquisition Corp IIN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEUCREucrates Biomedical Acquisition$2.42MN/A0.00∞N/AN/A-62.82%2.95%N/AMCAAMountain & Co. I Acquisition Corp.N/AN/A0.00∞N/AN/AN/AN/AN/ARFAIRF Acquisition Corp IIN/AN/A0.00∞N/AN/AN/AN/AN/AROSSRoss Acquisition Corp II$14.87MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEUCREucrates Biomedical AcquisitionN/AN/AN/AN/AN/AMCAAMountain & Co. I Acquisition Corp.N/AN/AN/AN/AN/ARFAIRF Acquisition Corp IIN/AN/AN/AN/AN/AROSSRoss Acquisition Corp IIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEUCREucrates Biomedical AcquisitionN/A2.032.03MCAAMountain & Co. I Acquisition Corp.N/AN/AN/ARFAIRF Acquisition Corp IIN/AN/AN/AROSSRoss Acquisition Corp IIN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEUCREucrates Biomedical Acquisition56.02%MCAAMountain & Co. I Acquisition Corp.64.23%RFAIRF Acquisition Corp IIN/AROSSRoss Acquisition Corp II27.79%Insider OwnershipCompanyInsider OwnershipEUCREucrates Biomedical Acquisition19.50%MCAAMountain & Co. I Acquisition Corp.4.18%RFAIRF Acquisition Corp IIN/AROSSRoss Acquisition Corp II76.37%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEUCREucrates Biomedical Acquisition44.21 million3.39 millionNot OptionableMCAAMountain & Co. I Acquisition Corp.2,02114.13 million13.54 millionNot OptionableRFAIRF Acquisition Corp IIN/A15.01 millionN/AN/AROSSRoss Acquisition Corp II313.67 million3.23 millionNot OptionableEUCR, MCAA, RFAI, and ROSS HeadlinesRecent News About These CompaniesRoss Video targets $1B revenue by 2030, shifts from IPO plansNovember 26, 2024 | newscaststudio.comAbbVie’s stock plummets over 12% after schizophrenia drug flops in Phase II trialsNovember 12, 2024 | finance.yahoo.comNewbury Street II Acquisition Corp Announces Closing of $172.5 Million Initial Public OfferingNovember 5, 2024 | markets.businessinsider.comGroq CEO Jonathan Ross reveals strategy to lead AI chip marketOctober 24, 2024 | yahoo.comDarren Walker Is Named President of the National Gallery of Art in Washington, D.C.October 17, 2024 | news.yahoo.comDarren Walker to Helm the National Gallery of Art in Washington, D.C.October 16, 2024 | msn.comFormer Congressman Dave Hobson had huge impact on the Springfield-Dayton areaOctober 13, 2024 | daytondailynews.comJohn Ross Quigley Announces Filing of Early Warning Report Related to Historical Transactions of Acquisitions of Securities of Advanced Gold Exploration Inc.October 4, 2024 | msn.comMiami Dolphins Owner Ross Nears Selling Stakes to Ares, Tsai (2)October 3, 2024 | news.bloomberglaw.comBest gifts for women 2024: Present ideas she will loveSeptember 27, 2024 | msn.comHOT PROPERTIES: Indoor golf simulator finds home in CharlestonSeptember 25, 2024 | scbiznews.comRoss Clark Named CEO of Adventure Media HoldingsSeptember 15, 2024 | toybook.comRoss school board race draws 3 candidates for 2 seatsSeptember 7, 2024 | msn.comPICC Group Sees Strong New Business Growth Continues on Commission Rate CutAugust 30, 2024 | morningstar.comMan Pulls a 'Mike Ross' by Lying To Get Senior Job—Experts Debate RisksAugust 24, 2024 | msn.comA farm bug in the housing boom | Ross Eric Gibson, Local HistoryAugust 18, 2024 | msn.comH&R Block tops Q4 earnings, Harris unveils housing plans: Wealth!August 17, 2024 | uk.finance.yahoo.comDigital Ally, Inc.: Digital Ally, Inc Announces Second Quarter 2024 Operating ResultsAugust 17, 2024 | finanznachrichten.deRoss Dalton Rejoins GTECH as Senior Vice President, Printed Products and Licensed Content MarketsAugust 17, 2024 | br.advfn.comHow Elon Musk is driving users from Twitter en masseAugust 15, 2024 | heraldscotland.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEUCR, MCAA, RFAI, and ROSS Company DescriptionsEucrates Biomedical Acquisition NASDAQ:EUCREucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.Mountain & Co. I Acquisition Corp. NASDAQ:MCAA$11.39 0.00 (0.00%) As of 05/27/2025Mountain & Co. I Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in consumer Internet and B2B digital infrastructure sectors. The company was incorporated in 2021 and is based in Wilmington, Delaware.RF Acquisition Corp II NASDAQ:RFAI$10.49 +0.01 (+0.10%) Closing price 05/30/2025 10:04 AM EasternExtended Trading$10.49 0.00 (0.00%) As of 07:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RF Acquisition Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 5, 2024, and is headquartered in Singapore.Ross Acquisition Corp II NYSE:ROSS$11.08 0.00 (0.00%) As of 05/30/2025Ross Acquisition Corp II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Ross Acquisition Corp II was incorporated in 2021 and is based in Palm Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell 5 Reasons Costco Stock Will Hit New Highs This Year Ackman Takes a Swing at Amazon — Should You? Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results? Intel’s Turnaround May Be the Best Bet No One’s Watching Apple’s Quiet HomePad Delay Could Be Its Loudest Move Yet Nike’s Amazon Expansion Could Signal a Turnaround in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
